Filing Details

Accession Number:
0001214659-24-005016
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-22 16:05:29
Reporting Period:
2024-03-20
Accepted Time:
2024-03-22 16:05:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581280 Twist Bioscience Corp TWST Biological Products, (No Disgnostic Substances) (2836) 462058888
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753655 M. Emily Leproust C/O Twist Bioscience Corporation
681 Gateway Blvd.
South San Francisco CA 94080
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-20 1,128 $33.52 515,281 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Option (right to buy) $5.95 2025-09-28 0 24,360 Direct
Common Stock Employee Stock Option (right to buy) $8.82 2027-09-28 0 150,879 Direct
Common Stock Employee Stock Option (right to buy) $26.66 2028-11-18 0 266,539 Direct
Common Stock Employee Stock Option (right to buy) $23.33 2029-10-23 0 131,290 Direct
Common Stock Employee Stock Option (right to buy) $67.85 2022-12-19 2030-08-31 64,950 64,950 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-09-28 0 24,360 Direct
2027-09-28 0 150,879 Direct
2028-11-18 0 266,539 Direct
2029-10-23 0 131,290 Direct
2030-08-31 64,950 64,950 Direct
Footnotes
  1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
  2. Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  3. The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  4. The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  5. 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  6. 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  7. Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.